- ►diabetesjournals.org A Pfützner, T Kunt, C Hohberg, A Mondok, S Pahler, … - Diabetes Care, 2004 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—In total, 48 patients with type 2 diabetes (20 women and 28 men, aged
60 ± 9 years [means ± SD], diabetes duration 5.1 ± 3.8 years, BMI 31.2 ± 4.8 kg/m 2 , and HbA 1c
6.9 ± 1.2%) were studied by means ... Cited by 61 - Related articles - BL Direct - All 7 versions
JS Yudkin, M May, P Elwood, JWG Yarnell, R … - Diabetologia, 2002 - Springer Aims/hypothesis. Higher concentrations of insulin correlate with several coronary heart disease
(CHD) risk factors and have been shown to predict incident CHD in several studies, leading to
hypotheses con- cerning the ... Cited by 43 - Related articles - BL Direct - All 5 versions
A Pfützner, T Kunt, M Langenfeld, M Löbig … - Clinical Chemistry …, 2003 - reference-global.com Measurement of proinsulin is an important tool in the assessment of pancreatic ß cell function in
patients with type 2 diabetes. The goal of this study was to per- form a technical and clinical
evaluation of two specific ... Cited by 8 - Related articles - All 5 versions
A Pfützner, C Hohberg, G Lübben, S Pahler, AH … - Hormone and metabolic …, 2005 - cat.inist.fr New scores and biochemical markers have recently been published for diagnosis of insulin resistance
and β-cell dysfunction(such as intact proinsulin, adiponectin, IRISII-score). One goal of this
6-month prospective controlled ... Cited by 21 - Related articles - BL Direct - All 4 versions
A Pfützner, T Schöndorf, D Seidel, K Winkler, S … - Metabolism, 2006 - Elsevier Addition of rosiglitazone to sulfonylurea has been shown to improve glycemic control in patients
with type 2 diabetes previously treated with sulfonylurea monotherapy alone. This investigation was
performed to assess the specific ... Cited by 39 - Related articles - All 17 versions
- Free from Publisher M Alssema, JM Dekker, G Nijpels, CDA Stehouwer, LM … - Diabetes care, 2005 - cat.inist.fr OBJECTIVE- High proinsulin concentration may be a better predictor for cardiovascular disease(CVD)
mortality than insulin concentration. Previous observations may have been confounded by glucose
tolerance status or lack of ... Cited by 17 - Related articles - All 3 versions
JA Galloway, SA Hooper, CT Spradlin, DC Howey, … - Diabetes Care, 1992 - Am Diabetes Assoc OBJECTIVE--To describe the rationale for the preclinical and clinical developmental course of human
proinsulin (HPI), the second product after human insulin for the treatment of diabetes mellitus to
be manufactured by DNA technology. ... Cited by 90 - Related articles - All 6 versions
JS Yudkin, AE Denver, V Mohamed-Ali, KL … - Diabetes Care, 1997 - Am Diabetes Assoc OBJECTIVE: To define the potential role of proinsulin-like molecules as risk factors for
cardiovascular disease. RESEARCH DESIGN AND METHODS: Fasting concentrations of proinsulin,
des-31,32-proinsulin, and insulin, ... Cited by 46 - Related articles - BL Direct - All 5 versions
